Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.

Julian Panes James O Lindsay Niels TeichStefan LindgrenJean Frederic ColombelHeather Ann FlynnSusan HuyckRuji YaoGeorge Philip Walter Reinisch

Published in: Inflammatory bowel diseases (2022)

Colectomy was reported at a higher rate in the IFX group than in the ConvRx group, although patients in the IFX group had more severe disease at baseline and most of the colectomies occurred after patients had been off of IFX for ≥90 days.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ulcerative colitis
prognostic factors
risk factors
patient reported outcomes
big data
deep learning
artificial intelligence